We have monitored the interactions of DNA strands immobilized on silica at the buried solid/liquid interface using vibrational sum frequency generation. We find that the nucleobases exhibit net order even prior to hybridization for immobilized single strands. Moreover, varying the temperature of the hybridized samples leads to spectral changes from the thymine nucleobases that are consistent with duplex dissociation.
The copper(I)-mediated azide-alkyne cycloaddition (CuAAC) of 3'-propargyl ether and 5'-azide oligonucleotides is a particularly promising ligation system because it results in triazole linkages that effectively mimic the phosphate-sugar backbone of DNA, leading to unprecedented tolerance of the ligated strands by polymerases. However, for a chemical ligation strategy to be a viable alternative to enzymatic systems, it must be equally as rapid, as discriminating, and as easy to use. We found that the DNA-templated reaction with these modifications was rapid under aerobic conditions, with nearly quantitative conversion in 5 min, resulting in a k value of 1.1 min , comparable with that measured in an enzymatic ligation system by using the highest commercially available concentration of T4 DNA ligase. Moreover, the CuAAC reaction also exhibited greater selectivity in discriminating C:A or C:T mismatches from the C:G match than that of T4 DNA ligase at 29 °C; a temperature slightly below the perfect nicked duplex dissociation temperature, but above that of the mismatched duplexes. These results suggest that the CuAAC reaction of 3'-propargyl ether and 5'-azide-terminated oligonucleotides represents a complementary alternative to T4 DNA ligase, with similar reaction rates, ease of setup and even enhanced selectivity for certain mismatches.
Gene-editing
systems such as CRISPR-Cas9 readily enable individual
gene phenotypes to be studied through loss of function. However, in
certain instances, gene compensation can obfuscate the results of
these studies, necessitating the editing of multiple genes to properly
identify biological pathways and protein function. Performing multiple
genetic modifications in cells remains difficult due to the requirement
for multiple rounds of gene editing. While fluorescently labeled guide
RNAs (gRNAs) are routinely used in laboratories for targeting CRISPR-Cas9
to disrupt individual loci, technical limitations in single gRNA (sgRNA)
synthesis hinder the expansion of this approach to multicolor cell
sorting. Here, we describe a modular strategy for synthesizing sgRNAs
where each target sequence is conjugated to a unique fluorescent label,
which enables fluorescence-activated cell sorting (FACS) to isolate
cells that incorporate the desired combination of gene-editing constructs.
We demonstrate that three short strands of RNA functionalized with
strategically placed 5′-azide and 3′-alkyne terminal
deoxyribonucleotides can be assembled in a one-step, template-assisted,
copper-catalyzed alkyne–azide cycloaddition to generate fully
functional, fluorophore-modified sgRNAs. Using these synthetic sgRNAs
in combination with FACS, we achieved selective cleavage of two targeted
genes, either separately as a single-color experiment or in combination
as a dual-color experiment. These data indicate that our strategy
for generating double-clicked sgRNA allows for Cas9 activity in cells.
By minimizing the size of each RNA fragment to 41 nucleotides or less,
this strategy is well suited for custom, scalable synthesis of sgRNAs.
Correction for 'The presence of a 5'-abasic lesion enhances discrimination of single nucleotide polymorphisms while inducing an isothermal ligase chain reaction' by Abu Kausar et al., Analyst, 2016, 141, 4272-4277.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.